These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 4811243)

  • 1. Identification of two new metabolites of hydralazine from human urine.
    Zak SB; Gilleran TG; Karliner J; Lukas G
    J Med Chem; 1974 Mar; 17(3):381-2. PubMed ID: 4811243
    [No Abstract]   [Full Text] [Related]  

  • 2. Identification of 3-methyl-s-triazolo(3,4-alphathalazine, a human hydralazine metabolite, by gas chromatography-mass spectrometry.
    Zimmer H; Kokosa J; Garteiz DA
    Arzneimittelforschung; 1973 Aug; 23(8):1028-9. PubMed ID: 4801020
    [No Abstract]   [Full Text] [Related]  

  • 3. 3-Hydroxymethyl-s-triazolo[3,4-a]phthalazine, a novel urinary hydralazine metabolite in man.
    Zimmer H; Glaser R; Kokosa J; Garteiz DA; Hess EV; Litwin A
    J Med Chem; 1975 Oct; 18(10):1031-3. PubMed ID: 1159684
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Determination of hydralazine metabolites: 4-hydrazino-phthalazin-1-one and n-acetylhydrazinophthalazin-1-one by gas chromatography and s-triazolo[3,4-alpha]phthalazine and phthalazinone by high-performance liquid chromatography.
    Facchini V; Timbrell JA
    J Chromatogr; 1980 Aug; 183(2):167-73. PubMed ID: 7400275
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Studies in the rabbit on 3-methyltriazolophthalazine, an acetylated metabolite of hydralazine. Evidence for an alternative route of formation.
    Talseth T; Haegele KD; McNay JL
    Drug Metab Dispos; 1980; 8(2):73-6. PubMed ID: 6103791
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification and quantitation of hydrazine in the urine of patients treated with hydralazine.
    Timbrell JA; Harland SJ
    Clin Pharmacol Ther; 1979 Jul; 26(1):81-8. PubMed ID: 445966
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metabolism of hydralazine in man.
    Wagner J; Faigle JW; Imhof P; Liehr G
    Arzneimittelforschung; 1977; 27(12):2388-95. PubMed ID: 580056
    [No Abstract]   [Full Text] [Related]  

  • 8. Metabolism and disposition of hydralazine-14C in man and dog.
    Lesser JM; Israili ZH; Davis DC; Dayton PG
    Drug Metab Dispos; 1974; 2(4):351-60. PubMed ID: 4153405
    [No Abstract]   [Full Text] [Related]  

  • 9. Hydralazine urinary metabolites in systemic lupus erythematosus.
    Litwin A; Adams LE; Hess EV; McManus J; Zimmer H
    Arthritis Rheum; 1973; 16(2):217-20. PubMed ID: 4716433
    [No Abstract]   [Full Text] [Related]  

  • 10. Metabolites of 3-hydrazino-6-[bis-(2-hydroxyethyl)amino]pyridazine dihydrochloride in rat urine.
    Beretta E; Cristina T; Ferrari P; Tuan G; Zerilli LF; Martinelli E
    Eur J Drug Metab Pharmacokinet; 1979; 4(1):29-33. PubMed ID: 38122
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Disposition of hydralazine in man and a specific method for its determination in biological fluids.
    Zak SB; Bartlett MF; Wagner WE; Gilleran TG; Lukas G
    J Pharm Sci; 1974 Feb; 63(2):225-9. PubMed ID: 4813244
    [No Abstract]   [Full Text] [Related]  

  • 12. Further evidence for an acetylator phenotype difference in the metabolism of hydralazine in man.
    Facchini V; Timbrell JA
    Br J Clin Pharmacol; 1981 Apr; 11(4):345-51. PubMed ID: 7259927
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of dose on acetylator phenotype distribution of hydralazine.
    Timbrell JA; Harland SJ; Facchini V
    Clin Pharmacol Ther; 1981 Mar; 29(3):337-43. PubMed ID: 7471604
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Absorption, tissue distribution, and excretion of the anti-neoplastic agent guanazole in the rat.
    Musa MN; Lower GM; Welling PG; Johnson BM; Kaiman BD; Bryan GT
    Res Commun Chem Pathol Pharmacol; 1974 Mar; 7(3):497-512. PubMed ID: 4824824
    [No Abstract]   [Full Text] [Related]  

  • 15. Determination of hydralazine and metabolites in urine by liquid chromatography with electrochemical detection.
    Ravichandran K; Baldwin RP
    J Chromatogr; 1985 Sep; 343(1):99-108. PubMed ID: 4066866
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of the decomposition products of hydralazine hydrazones with three endogenous ketones and kinetic study of the formation of 3-methyl-s-triazolo[3,4,a]phthalazine from hydralazine and pyruvic acid].
    Nakano M; Tomitsuka T; Juni K
    Chem Pharm Bull (Tokyo); 1980 Nov; 28(11):3407-11. PubMed ID: 7214613
    [No Abstract]   [Full Text] [Related]  

  • 17. [Biotransformation of pyridazines. 1. Pyridazine and 3-methylpyridazine].
    Borchert HH; Pfeifer S; Helbig B; Franke P; Heinisch G
    Pharmazie; 1989 Sep; 44(9):625-30. PubMed ID: 2608708
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Determination of hydralazine and its metabolites by gas chromatography-mass spectrometry.
    Haegele KD; Skrdlant HB; Robie NW; Lalka D; McNay JL
    J Chromatogr; 1976 Nov; 126():517-34. PubMed ID: 977694
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The use of low-energy collisionally activated dissociation negative-ion tandem mass spectrometry for the characterization of dog and human urinary metabolites of the drug BW 1370U87.
    Taylor LC; Johnson RL; St John-Williams L; Johnson T; Chang SY
    Rapid Commun Mass Spectrom; 1994 Mar; 8(3):265-73. PubMed ID: 8167371
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Polymorphic acetylation of hydralazine.
    Timbrell JA; Harland SJ; Facchini V
    Clin Pharmacol Ther; 1980 Sep; 28(3):350-5. PubMed ID: 7408395
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.